India’s radiotherapy device market is entering a high-growth phase, driven by a sharp rise in cancer cases, expanding healthcare infrastructure, and increased public investment in oncology care. Industry estimates indicate the market could more...
Novo Nordisk’s weight loss drug has shown promising liver benefits in a new preclinical study, pointing to effects beyond just shedding pounds. Researchers found that the company’s GLP-1-based treatment improved liver health in mice, even when...
As India’s biotechnology sector enters a high-growth phase, a key question is emerging: can it deliver breakthrough therapies globally? In the latest episode of the “What India Needs!” podcast, host Shutapa Paul spoke with Dr Jogin Desai, Found...
MSN Laboratories launches Semabest, a semaglutide drug priced 50% lower in India, boosting access to advanced diabetes treatment for millions.
The US Food and Drug Administration has asked Eli Lilly to submit additional safety data for its newly approved weight-loss pill, Foundayo, even as the drug begins entering the market.
India’s homeopathy industry is seeing a steady rise in global demand, supported by the government’s push to improve quality standards through the AYUSH Premium Mark initiative. Experts believe this move is helping build trust in Made in Indi...
The Bajaj Group has announced its entry into India’s healthcare sector with an investment of ?2,000–?2,500 crore to build an integrated healthcare network. This move marks a major diversification for the long-established business grou...
The essential drugs price hike due to Iran war is starting to reflect in India’s pharmaceutical market, with reports indicating that prices of key medicines may rise by up to 5 percent in the near term.
AbbVie has shared promising results from a Phase 2 clinical trial testing a new combination treatment for ovarian cancer, offering fresh hope for patients with limited options.
India is set to overhaul how biosimilar drugs are approved, with regulators proposing a major shift that could cut costs, speed up access, and reshape the pharmaceutical landscape. According to a report, DGCI is working on new biosimilar...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")